Sign in to continue:

Thursday, July 30th, 2026

Day: June 10, 2026

Axsome Therapeutics Adopts Executive Severance and Change in Control Plan – SEC 8-K Filing June 2026

Axsome Therapeutics Adopts Executive Severance and Change in...

AI Era Corp. Files 8-K Report Announcing Director Changes and Company Details – June 2026

AI Era Corp. Files Form 8-K: Key Highlights for Investors ...

Bluejay Diagnostics Amends 2021 Stock Plan and Ratifies Auditor in June 2026 8-K Filing

Bluejay Diagnostics, Inc. Announces Key Results from 2026 An...